High sodium intake modulates left ventricular mass in patients with G expression of +1675 G/A angiotensin II receptor type 2 gene

Journal of Hypertension

Volumn 25, Issue 8, 2007, Pages 1627-1632

  Ott, Christian ^a   Titze, Stephanie I ^a   Schwarz, Thomas K ^a   Kreutz, Reinhold ^b   Hilgers, Karl F ^a   Schmidt, Bernhard M W ^a   Schlaich, Markus P ^a   Schmieder, Roland E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

+1675 A G polymorphism; Angiotensin receptor gene; Gene environment interaction; Left ventricular hypertrophy; Salt intake

Indexed keywords

ANGIOTENSIN 2 RECEPTOR;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; COVARIANCE; ECHOCARDIOGRAPHY; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE FUNCTION; HIGH SODIUM INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL;

EID: 34447300163     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3281cd40f5     Document Type: Article

References (36)

1. Lieb W, Graf J, Gotz A, Konig IR, Mayer B, Fischer M, et al. Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy. J Mol Med 2006; 84:88-96.
2. Schmieder RE. The role of nonhaemodynamic factors of the genesis of LVH. Nephrol Dial Transplant 2005; 20:2610-2612.
3. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, et al. Association between a deletion polymorphism of the angiotensin- converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330:1634-1638.
4. Schmieder RE, Erdmann J, Delles C, Jacobi J, Fleck E, Hilgers K, Regitz-Zagrosek V. Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans. J Am Coll Cardiol 2001; 37:175-182.
5. Martin MM, Elton TS. The sequence and genomic organization of the human type 2 angiotensin II receptor. Biochem Biophys Res Commun 1995; 209:554-562.
6. Warnecke C, Willich T, Holzmeister J, Bottari SP, Fleck E, Regitz-Zagrosek V. Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements. Biochem J 1999; 340:17-24.
7. Warnecke C, Mugrauer P, Surder D, Erdmann J, Schubert C, Regitz-Zagrosek V. Intronic ANG II type 2 receptor gene polymorphism 1675 G/A modulates receptor protein expression but not mRNA splicing. Am J Physiol Regul Integr Comp Physiol 2005; 289:R1729-R1735.
8. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52:415-472.
9. Tsutsumi Y, Matsubara H, Ohkubo N, Mori Y, Nozawa Y, Murasawa S, et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res 1998; 83:1035-1046.
10. Janiak P, Pillon A, Prost JF, Vilaine JP. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 1992; 20:737-745.
11. Ichihara S, Senbonmatsu T, Price E Jr, Ichiki T, Gaffney FA, Inagami T. Targeted deletion of angiotensin II type 2 receptor caused cardiac rupture after acute myocardial infarction. Circulation 2002; 106:2244-2249.
12. Wang L, Flannery PJ, Spurney RF. Characterization of angiotensin IIreceptor subtypes in podocytes. J Lab Clin Med 2003; 142:313-321.
13. Herrmann SM, Nicaud V, Schmidt-Petersen K, Pfeifer J, Erdmann J, McDonagh T, et al. Angiotensin II type 2 receptor gene polymorphism and cardiovascular phenotypes: the GLAECO and GLAOLD studies. Eur J Heart Fail 2002; 4:707-712.
14. Fischer M, Baessler A, Luchner A, Hense HW, Regitz-Zagrosek V, Riegger G, et al. The human +1675 A/G polymorphism influences the left ventricular structure in hypertensive males [Abstract] [in German]. Z Kardiol 2002; 91 (Suppl 1):V38.
15. Oishi Y, Ozono R, Yano Y, Teranishi Y, Akishita M, Horiuchi M, et al. Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling. Hypertension 2003; 41:814-818.
16. Voros S, Yang Z, Bove CM, Gilson WD, Epstein FH, French BA, et al. Interaction between AT1 and AT2 receptors during postinfarction left ventricular remodeling. Am J Physiol Heart Circ Physiol 2006; 290:H1004-H1010.
17. Messerli FH, Schmieder RE, Weir MR. Salt. A perpetrator of hypertensive target organ disease? Arch Intern Med 1997; 157:2449-2452.
18. Sanders PW. Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension 2004; 43:142-146.
19. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 2005; 85:679-715.
20. Schmieder RE, Langenfeld MR, Friedrich A, Schobel HP, Gatzka CD, Weihprecht H. Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation 1996; 94:1304-1309.
21. Du Cailar G, Ribstein J, Mimran A. Dietary sodium and target organ damage in essential hypertension. Am J Hypertens 2002; 15:222-229.
22. Sanders PW. Effect of salt intake on progression of chronic kidney disease. Curr Opin Nephrol Hypertens 2006; 15:54-60.
23. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P, Nissinen A. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001; 357:848-851.
24. Rugale C, Delbosc S, Cristol JP, Mimran A, Jover B. Sodium restriction prevents cardiac hypertrophy and oxidative stress in angiotensin II hypertension. Am J Physiol Heart Circ Physiol 2003; 284:H1744- H1750.
25. Gu JW, Anand V, Shek EW, Moore MC, Brady AL, Kelly WC, Adair TH. Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells. Hypertension 1998; 31:1083-1087.
26. Delles C, Erdmann J, Jacobi J, Hilgers KF, Fleck E, Regitz-Zagrosek V, Schmieder RE. Aldosterone synthase (CYP11B2) -344 C/T polymorphism is associated with left ventricular structure in human arterial hypertension. J Am Coll Cardiol 2001; 37:878-884.
27. European Society of Hypertension. European Society of Cardiology 2003 guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
28. Luft FC, Fineberg NS, Sloan RS. Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake. Hypertension 1982; 4:805-808.
29. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
30. Schmieder RE, Messerli FH. Determinants of ventricular ectopy in hypertensive cardiac hypertrophy. Am Heart J 1992; 123:89-95.
31. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
32. Kuznetsova T, Staessen JA, Thijs L, Kunath C, Olszanecka A, Ryabikov A, et al. Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion. Circulation 2004; 110:2644-2650.
33. Armando I, Jezova M, Juorio AV, Terron JA, Falcon-Neri A, Semino-Mora C, et al. Estrogen upregulates renal angiotensin II AT(2) receptors. Am J Physiol Renal Physiol 2002; 283:F934-F943.
34. Kitiyakara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, et al. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 2003; 14:2775-2782.
35. Ketonen J, Merasto S, Paakkari I, Mervaala EM. High sodium intake increases vascular superoxide formation and promotes atherosclerosis in apolipoprotein E-deficient mice. Blood Press 2005; 14:373-382.
36. Kuznetsova T, Staessen JA, Brand E, Cwynar M, Stolarz K, Thijs L, et al. Sodium excretion as a modulator of genetic associations with cardiovascular phenotypes in the European Project on Genes in Hypertension. J Hypertens 2006; 24:235-242.